Cargando…
IGFBP‐4 enhances VEGF‐induced angiogenesis in a mouse model of myocardial infarction
Vascular endothelial growth factor (VEGF) is a well‐known angiogenic factor, however its ability in promoting therapeutic angiogenesis following myocardial infarction (MI) is limited. Here, we aimed to investigate whether dual treatment with insulin‐like growth factor binding protein‐4 (IGFBP‐4), an...
Autores principales: | Wo, Da, Chen, Jinxiao, Li, Qiongyu, Ma, En, Yan, Hongwei, Peng, Jun, Zhu, Weidong, Fang, Yong, Ren, Dan‐ni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417680/ https://www.ncbi.nlm.nih.gov/pubmed/32597006 http://dx.doi.org/10.1111/jcmm.15516 |
Ejemplares similares
-
Network pharmacology-based analysis in determining the mechanisms of Huoxin pill in protecting against myocardial infarction
por: He, Jia, et al.
Publicado: (2021) -
Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt/β‑catenin signaling
por: Wang, Qing, et al.
Publicado: (2021) -
Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37
por: Chen, Jinxiao, et al.
Publicado: (2019) -
Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activation
por: Gao, Qian, et al.
Publicado: (2022) -
Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway
por: Qiu, Zhengliang, et al.
Publicado: (2023)